Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

Links shared publicly online about this topic.

  • 18
    total visits

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

news-medical.net —

BioDelivery Sciences International, Inc. announced positive preliminary results from its Phase 1 study assessing the pharmacokinetics of a BEMA Buprenorphine/Naloxone formulation.

View full resource at news-medical.net

Tags: Phase 1 Clinical Trial, Pharmacokinetics, Oncology, News, Science, Opiate

  • Share

Most Recently Shared on September 6, 2011 at 2:42 pm By:

NewsMedical News-Medical.Net

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence: BioDeli... http://t.co/rY1HPWg

8 months ago...

Reply

Retweet

Favorite

Also Shared By:

News-Medical.Net News-Medical.Net

Advertisement